XHXiayuan Huang

Xiayuan Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xiayuan Huang has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Zuoheng Wang

    Department of Biostatistics, Yale University School of Public Health , 300 George Street, New Haven, CT 06511

    3 shared publications
  • Abdullah Mesut Erzurumluoglu

    Human Genetics, Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riβ 88400, Germany

    2 shared publications
  • Daniel Lam

    CB CMDR, Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riβ 88400, Germany

    2 shared publications
  • Hongyu Zhao

    Department of Biostatistics, Yale University School of Public Health , New Haven, CT 06510

    2 shared publications
  • Jatin Arora

    Human Genetics, Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riβ 88400, Germany

    2 shared publications
  • Zhihao Ding

    Human Genetics, Global Computational Biology and Digital Sciences, Boehringer Ingelheim Pharma GmbH & Co. KG , Biberach an der Riβ 88400

    2 shared publications

Latest Publications

  • Top Cited Papers
    Open Access

    Pharmaco-behavioral profiling identifies suppressors of autism gene–associated phenotypes in zebrafish

    by Priyanka Jamadagni, Yi Dai, Yunqing Liu, Hellen Weinschutz Mendes, April Pruitt, Suha Khan, Liang Yang, Tzu-Chieh Huang, Xiayuan Huang, P. J. Michael Deans, et al.

    Pharmaco-behavioral screens in scalable in vivo systems have critical advantages for drug discovery relevant to large-effect autism spectrum disorder (ASD) genes. Here, we establish a database and open-source website of the behavioral signatures of 520 US Food and Drug Administration (FDA)-approved drugs using high-throughput assays of basic sensory processing and arousal behaviors in larval zebrafish. By leveraging the behavioral profiles of 9 large-effect ASD gene mutants, we identify enrichment of pharmacological mechanisms that anticorrelate with subgroups of ASD genes with shared behavioral phenotypes. Screening of anticorrelating drugs in mutants of two ASD genes, SCN2A and DYRK1A , uncovers compounds that suppress mutant behavioral phenotypes. We identify estropipate, an estrogen receptor agonist, and paclitaxel, a microtubule inhibitor, as the top suppressors in scn1lab and dyrk1a mutants, respectively, and levocarnitine (LEVO), a mitochondrial modulator and carnitine supplement, as a top suppressor of both mutant behavioral phenotypes. Finally, we find that LEVO rescues regional brain activity deficits and dysregulated lipid metabolic pathways in mutants, as well as signaling deficits in human pluripotent stem cell–derived glutamatergic neurons carrying mutations in SCN2A and DYRK1A , demonstrating conservation of drug rescue across systems. Therefore, our study establishes a pharmaco-behavioral resource for precision medicine-based drug discovery, illuminating targets relevant to large-effect ASD genes.


  • Open Access

    Association Between Risk Factors and Major Cancers: Explainable Machine Learning Approach

    by Xiayuan Huang, Shushun Ren, Xinyue Mao, Sirui Chen, Elle Chen, Yuqi He, Yun Jiang

    Background: Cancer is a life-threatening disease and a leading cause of death worldwide, with an estimated 611,000 deaths and over 2 million new cases in the United States in 2024. The rising incidence of major cancers, including among younger individuals, highlights the need for early screening and monitoring of risk factors to manage and decrease cancer risk. Objective: This study aimed to leverage explainable machine learning models to identify and analyze the key risk factors associated with breast, colorectal, lung, and prostate cancers. By uncovering significant associations between risk factors and these major cancer types, we sought to enhance the understanding of cancer diagnosis risk profiles. Our goal was to facilitate more precise screening, early detection, and personalized prevention strategies, ultimately contributing to better patient outcomes and promoting health equity. Methods: Deidentified electronic health record data from Medical Information Mart for Intensive Care (MIMIC)–III was used to identify patients with 4 types of cancer who had longitudinal hospital visits prior to their diagnosis presence. Their records were matched and combined with those of patients without cancer diagnoses using propensity scores based on demographic factors. Three advanced models, penalized logistic regression, random forest, and multilayer perceptron (MLP), were conducted to identify the rank of risk factors for each cancer type, with feature importance analysis for random forest and MLP models. The rank biased overlap was adopted to compare the similarity of ranked risk factors across cancer types. Results: Our framework evaluated the prediction performance of explainable machine learning models, with the MLP model demonstrating the best performance. It achieved an area under the receiver operating characteristic curve of 0.78 for breast cancer (n=58), 0.76 for colorectal cancer (n=140), 0.84 for lung cancer (n=398), and 0.78 for prostate cancer (n=104), outperforming other baseline models (P<.001). In addition to demographic risk factors, the most prominent nontraditional risk factors overlapped across models and cancer types, including hyperlipidemia (odds ratio [OR] 1.14, 95% CI 1.11‐1.17; P<.01), diabetes (OR 1.34, 95% CI 1.29‐1.39; P<.01), depressive disorders (OR 1.11, 95% CI 1.06‐1.16; P<.01), heart diseases (OR 1.42, 95% CI 1.32‐1.52; P<.01), and anemia (OR 1.22, 95% CI 1.14‐1.30; P<.01). The similarity analysis indicated the unique risk factor pattern for lung cancer from other cancer types. Conclusions: The study’s findings demonstrated the effectiveness of explainable ML models in assessing nontraditional risk factors for major cancers and highlighted the importance of considering unique risk profiles for different cancer types. Moreover, this research served as a hypothesis-generating foundation, providing preliminary results for future investigation into cancer diagnosis risk analysis and management. Furthermore, expanding collaboration with clinical experts for external validation would be essential to refine model outputs, integrate findings into practice, and enhance their impact on patient care and cancer prevention efforts.


  • Enhancing patient representation learning with inferred family pedigrees improves disease risk prediction

    by Xiayuan Huang, Jatin Arora, Abdullah Mesut Erzurumluoglu, Stephen A Stanhope, Daniel Lam, Boehringer Ingelheim—Global Computational Biology and Digital Sciences, Pierre Khoueiry, Jan N Jensen, James Cai, Nathan Lawless, et al.

    Background: Machine learning and deep learning are powerful tools for analyzing electronic health records (EHRs) in healthcare research. Although family health history has been recognized as a major predictor for a wide spectrum of diseases, research has so far adopted a limited view of family relations, essentially treating patients as independent samples in the analysis. Methods: To address this gap, we present ALIGATEHR, which models inferred family relations in a graph attention network augmented with an attention-based medical ontology representation, thus accounting for the complex influence of genetics, shared environmental exposures, and disease dependencies. Results: Taking disease risk prediction as a use case, we demonstrate that explicitly modeling family relations significantly improves predictions across the disease spectrum. We then show how ALIGATEHR’s attention mechanism, which links patients’ disease risk to their relatives’ clinical profiles, successfully captures genetic aspects of diseases using longitudinal EHR diagnosis data. Finally, we use ALIGATEHR to successfully distinguish the 2 main inflammatory bowel disease subtypes with highly shared risk factors and symptoms (Crohn’s disease and ulcerative colitis). Conclusion: Overall, our results highlight that family relations should not be overlooked in EHR research and illustrate ALIGATEHR’s great potential for enhancing patient representation learning for predictive and interpretable modeling of EHRs.


  • Open Access

    Analyzing the Performance of Explainable Machine Learning Models in Risk Factor Identification for Major Cancers (Preprint)

    by Xiayuan Huang

    BACKGROUND Cancer is a life-threatening disease and a leading cause of death worldwide, with an estimated 611,000 deaths and over 2 million new cases in the United States in 2024. The rising incidence of major cancers, including among younger individuals, highlights the need for early screening and monitoring of risk factors to manage and decrease cancer risk. OBJECTIVE To identify pivotal factors essential for predicting the risk factors for four major cancer types (breast, colorectal, lung, and prostate) through the utilization of explainable machine learning techniques is imperative due to the increasing burden of cancer patients. METHODS De-identified electronic health record data from MIMIC-III was used to identify patients with four types of cancer who had longitudinal hospital visits prior to receiving a cancer diagnosis. Their records were matched and combined with those of patients without cancer diagnoses using propensity scores based on demographic factors. Three advanced models, penalized Logistic Regression (LR), Random Forest (RF), and Multilayer Perceptron (MLP), were conducted to identify the rank of risk factors for each cancer type, with feature importance analysis for RF and MLP models. The Rank Biased Overlap was adopted to compare the similarity of ranked risk factors across cancer types. RESULTS Our framework evaluated the prediction performance of explainable ML models, in which MLP achieved an AUC of 0.78 for breast cancer, 0.76 for colorectal cancer, 0.84 for lung cancer, and 0.78 for prostate cancer, respectively. In addition to demographic risk factors, the most prominent non-traditional risk factors overlapped across models and cancer types, including hyperlipidemia, diabetes, depressive disorders, heart diseases, and anemia. The similarity analysis indicated the unique risk factor pattern for lung cancer from other cancer types. CONCLUSIONS The study's findings demonstrate the effectiveness of explainable ML models in predicting non-traditional risk factors for major cancers and highlight the importance of considering unique risk profiles for different cancer types. These insights may contribute to efficient cancer screening and tailored cancer prevention strategies, which, in turn, offer fundamental support for clinical decision-making processes.

  • Open Access

    Enhancing patient representation learning from electronic health records through predicted family relations

    by Xiayuan Huang, Jatin Arora, Abdullah Mesut Erzurumluoglu, Daniel Lam, Hongyu Zhao, Zhihao Ding, Zuoheng Wang, Johann de Jong

    Artificial intelligence and machine learning are powerful tools in analyzing electronic health records (EHRs) for healthcare research. Despite the recognized importance of family health history, in healthcare research individual patients are often treated as independent samples, overlooking family relations. To address this gap, we present ALIGATEHR, which models predicted family relations in a graph attention network and integrates this information with a medical ontology representation. Taking disease risk prediction as a use case, we demonstrate that explicitly modeling family relations significantly improves predictions across the disease spectrum. We then show how ALIGATEHR’s attention mechanism, which links patients’ disease risk to their relatives’ clinical profiles, successfully captures genetic aspects of diseases using only EHR diagnosis data. Finally, we use ALIGATHER to successfully distinguish the two main inflammatory bowel disease subtypes (Crohn’s disease and ulcerative colitis), illustrating its great potential for improving patient representation learning for predictive and descriptive modeling of EHRs.

  • Open Access

    E-Pedigrees: a large-scale automatic family pedigree prediction application

    by Xiayuan Huang, Nicholas Tatonetti, Katie LaRow, Brooke Delgoffee, John Mayer, David Page, Scott J Hebbring

    The use and functionality of Electronic Health Records (EHR) have increased rapidly in the past few decades. EHRs are becoming an important depository of patient health information and can capture family data. Pedigree analysis is a longstanding and powerful approach that can gain insight into the underlying genetic and environmental factors in human health, but traditional approaches to identifying and recruiting families are low-throughput and labor-intensive. Therefore, high-throughput methods to automatically construct family pedigrees are needed. We developed a stand-alone application: Electronic Pedigrees, or E-Pedigrees, which combines two validated family prediction algorithms into a single software package for high throughput pedigrees construction. The convenient platform considers patients’ basic demographic information and/or emergency contact data to infer high-accuracy parent–child relationship. Importantly, E-Pedigrees allows users to layer in additional pedigree data when available and provides options for applying different logical rules to improve accuracy of inferred family relationships. This software is fast and easy to use, is compatible with different EHR data sources, and its output is a standard PED file appropriate for multiple downstream analyses. The Python 3.3+ version E-Pedigrees application is freely available on: https://github.com/xiayuan-huang/E-pedigrees.